Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Colorcon
McKinsey
Express Scripts
Medtronic

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for AGI-1096

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for AGI-1096?

AGI-1096 is an investigational drug.

There have been 4 clinical trials for AGI-1096. The most recent clinical trial was a Phase 1 trial, which was initiated on June 1st 2003.

The most common disease conditions in clinical trials are Colorectal Neoplasms, Coronary Artery Disease, and Carcinoma, Squamous Cell. The leading clinical trial sponsors are AtheroGenics, Agalimmune Ltd., and Celgene Corporation.

Recent Clinical Trials for AGI-1096
TitleSponsorPhase
Study to Evaluate Safety & Tolerability of AGI-134 in Solid TumourAgalimmune Ltd.Phase 1/Phase 2
PK and Safety Study of AG-221 in Healthy Male Japanese Subjects and Healthy Male Caucasian SubjectsCelgene CorporationPhase 1
ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation StudyAtheroGenicsPhase 2/Phase 3

See all AGI-1096 clinical trials

Clinical Trial Summary for AGI-1096

Top disease conditions for AGI-1096
Top clinical trial sponsors for AGI-1096

See all AGI-1096 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Harvard Business School
McKesson
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.